semaglutide news today october 2025 Novo Nordisk to present new data in oral 25 mg (Wegovy® in a pill*) and obesity pipeline at ObesityWeek® Ozempic's entry could reshape diabetes

Look out for these symptoms: Persistent feelings of sadness or hopelessness Loss of interest in activities once enjoyed Changes in appetite or sleep patterns Fatigue or loss of energy Difficulty concentrating or making decisions If you notice any of these signs, talk to your doctor right away

Wegovy (semaglutide) is a once-weekly GLP-1 receptor agonist that mimics the action of glucagon-like peptide-1, a natural gut hormone released after eating

On the other hand, such a model allows the detection of even small effects due to the high repeatability of the results

As demand for Ozempic increased in China, so did its price

Patients frequently describe it as a quiet reduction in food noise rather than a forced suppression of hunger